# The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2017

S.I. 2017/296 · made 1 March 2017

These Regulations amend Schedule 4 to the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 (S.I. 2012/2996) (“the principal Regulations”). Schedule 4 to the principal Regulations specifies services for rare and very rare conditions which the National Health Service Commissioning Board (“the Board”) must arrange for the provision of, as part of the health service.

Made under: National Health Service Act 2006 (Section 3B, Section 272)

PDFs: Printed copy https://openlegislation.uk/national-health-service-commissioning-board-and-clinical-commissioning-groups-responsibilities-and-standing-rules-amendment-regulations-2017/pdf/uksi_20170296_en.pdf; UK Explanatory Memorandum https://openlegislation.uk/national-health-service-commissioning-board-and-clinical-commissioning-groups-responsibilities-and-standing-rules-amendment-regulations-2017/pdf/uksiem_20170296_en.pdf

## Introductory text

National Health Service, England
Made 1st March 2017
Laid before Parliament 9th March 2017
Coming into force 1st April 2017
The Secretary of State for Health makes the following Regulations in exercise of the powers conferred by sections 3B(1) and 272(7)(a) and (b) of the National Health Service Act 2006.
In accordance with section 3B(4) of that Act, the Secretary of State obtained appropriate advice and consulted the National Health Service Commissioning Board before deciding to make these Regulations.

## 1 Citation and commencement

These Regulations may be cited as the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2017 and come into force on 1st April 2017.

## 2 Further service to be commissioned by the Board

(1) Schedule 4 (services for rare and very rare conditions) to the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 is amended as follows.
(2) After paragraph 140A, insert—
“140B. Uterine transplantation services.”.

## Signature

Signed by authority of the Secretary of State for Health.
O’Shaughnessy
Parliamentary Under-Secretary of State,
Department of Health
1st March 2017

## Explanatory note

(This note is not part of the Regulations)
These Regulations amend Schedule 4 to the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 (S.I. 2012/2996) (“the principal Regulations”). Schedule 4 to the principal Regulations specifies services for rare and very rare conditions which the National Health Service Commissioning Board (“the Board”) must arrange for the provision of, as part of the health service.
Regulation 2 amends Schedule 4 to give effect to the revised commissioning responsibilities for the Board pursuant to regulations 7, 10 and 11 of the principal Regulations.
This amendment follows advice received, and consultation with the Board, pursuant to the statutory procedures set out in section 3B(4) of the National Health Service Act 2006.
No impact assessment has been produced for these Regulations as they have no impact on the private sector and civil society organisations, and no significant effect on the public sector.

---
Source: https://www.legislation.gov.uk/uksi/2017/296 (the official version)
Page: https://openlegislation.uk/national-health-service-commissioning-board-and-clinical-commissioning-groups-responsibilities-and-standing-rules-amendment-regulations-2017
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.